Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion description "[Versican (chondroitin sulphate proteoglycan-2) is overexpressed in BPH and prostate cancer and potentially contributes to disease pathology.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion evidence source_evidence_literature NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion SIO_000772 15599946 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion wasDerivedFrom befree-20140225 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_assertion wasGeneratedBy ECO_0000203 NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.
- befree-20140225 importedOn "2014-02-25" NP211228.RABEmG-Hz2WcGOn2pCaLVRzwkfLWEOlmBfBrNzJ26NLpw130_provenance.